IgA Nephropathy: Clinical Trials

4 trials for IgA Nephropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 32Unknown 2

Follow IgA Nephropathy: new trials by email Literature Review of IgA Nephropathy trials Research Report on IgA Nephropathy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease
Placebo of SC0062, SC0062 low dose, SC0062 medium dose - Diabetic Kidney Disease, IgA Nephropathy
Phase 2UnknownBiocity Biopharmaceutics Co., Ltd.2552023-05-232025-01-07
Study of Telitacicept in Patients With Refractory IgA Nephropathy
Telitacicept - IgA Nephropathy
Phase 2 / Phase 3UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine402023-03-012023-02-24
Fecal Microbiota Transplantation for Refractory IgA Nephropathy
Fecal microbiota transplantation - IgA Nephropathy
Phase 2UnknownAir Force Military Medical University, China302017-11-222018-08-21
Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy
Prednisolone, Reh-acteoside - IGA Nephropathy
Phase 2 / Phase 3UnknownSun Yat-sen University752016-05-012016-02-02

Narrower conditions

Glomerulonephritis, IGA (4)  ·  Diabetic Nephropathies (1)

Broader conditions

Autoimmune Diseases (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Glomerulonephritis (4)  ·  Immune System Diseases (4)  ·  Kidney Diseases (4)  ·  Male Urogenital Diseases (4)  ·  Nephritis (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)

Interventions

Fecal Microbiota Transplantation (1)  ·  Prednisolone (1)  ·  telitacicept (1)

Sponsors

Air Force Military Medical University, China (1)  ·  Biocity Biopharmaceutics Co., Ltd. (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Sun Yat-sen University (1)

Countries

China (4)

Top investigators

Jianghua Chen, Prof (1)  ·  Shiren Sun, M.D. (1)  ·  Zongpei Jiang, M.D. & Ph.D. (1)

Results publications

PMID 38299639, PMID 39462310